US Patent Issued to Psy Therapeutics on April 29 for "Inhibiting monoacylglycerol lipase (MAGL)" (Massachusetts Inventor)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,286,421, issued on April 29, was assigned to Psy Therapeutics Inc. (Boston).

"Inhibiting monoacylglycerol lipase (MAGL)" was invented by Jacob Matthew Hooker (Winchester, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are compounds for inhibiting monoacylglycerol lipase (MAGL), and related methods of making and using the compounds."

The patent was filed on May 14, 2024, under Application No. 18/663,460.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=12286421&OS=12...